BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Micheva, I. [1 ]
Dimitrova, S. [1 ]
Rachev, R. [1 ]
Varbanov, H. [1 ]
Mehmed, M. [1 ]
Gerov, V. [1 ]
Antonov, A. [1 ]
Gercheva, L. [1 ]
机构：
[1] Univ Hosp, Haematol, Varna, Bulgaria
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1985
引用
收藏
页码：796 / 796
页数：1
相关论文
共 50 条
  • [1] Total therapy-based treatment for multiple myeloma-a single center experience
    Magen-Nativ, Hila
    Ram, Ron
    Yeshurun, Moshe
    Gafter-Gvili, Anat
    Raanani, Pia
    Shpilberg, Ofer
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 53 - 59
  • [2] Bortezomib in multiple myeloma: Treatment and retreatment. A single center experience
    Bilalis, Antonios G.
    Papadimitriou, Konstantinos
    Pouli, Anastasia
    Papanastasiou, Konstantinos
    Tsakanikas, Seraphem
    Stefanitsi, Panagiota
    Sioni, Anastasia
    Koropoulis, Georgios
    Stamatelou, Marina
    BLOOD, 2007, 110 (11) : 279B - 279B
  • [3] BORTEZOMIB IN MULTIPLE MYELOMA: TREATMENT AND RETREATMENT. A SINGLE CENTER EXPERIENCE
    Warzocha, Krzysztof
    Kraj, Maria
    Poglod, Ryszard
    Kwasniak, Beata
    ACTA POLONIAE PHARMACEUTICA, 2008, 65 (06): : 753 - 756
  • [4] Bortezomib in relapsed and refractory multiple myeloma patients.: Experience of a single center
    Calabrese, E.
    Gallucci, C.
    Federico, V
    Mohamad, A.
    Foa, R.
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [5] VDCR as a treatment option for refractory or relapsed multiple myeloma in Bortezomib pretreated patients, a single center experience
    Dobrosch, L.
    Hahn-Ast, C.
    Mayer, K.
    von Lilienfeld-Toal, M.
    Brossart, P.
    Janzen, V
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 162 - 162
  • [6] THE MAINTENANCE TREATMENT AS A THERAPEUTIC STRATEGY IN PATIENTS WITH MULTIPLE MYELOMA EXPERIENCE OF A CENTER
    Garcia Feria, A.
    Carretero, V
    Ferrandis, P.
    Pacios, A.
    Mosquera, D. P.
    Picon, I
    HAEMATOLOGICA, 2017, 102 : 290 - 290
  • [7] Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience
    Igarashi, Natsue
    Chou, Takaaki
    Hirose, Takayuki
    Imai, Yousuke
    Ishiguro, Takuro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) : 518 - 523
  • [8] Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience
    Natsue Igarashi
    Takaaki Chou
    Takayuki Hirose
    Yousuke Imai
    Takuro Ishiguro
    International Journal of Hematology, 2010, 92 : 518 - 523
  • [9] Efficacy of VDT PACE-like Regimens in Treatment of Relapsed / Refractory Multiple Myeloma-a Single Center Experience
    Lakshman, Arjun
    Singh, Preet Paul
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Hwa, Lisa
    Fonder, Amie
    Hobbs, Miriam
    Zeldenrust, Steven
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Warsame, Rahma
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [10] Supportive Care Utilization in Patients with Multiple Myeloma-a Single Center Retrospective Study
    Chang, Darryl
    Robinson, Myra
    Bose, Rupali
    Ehsan, Hamid
    Krishnan, Arunkumar
    Borden, Shanice
    Voorhees, Peter M.
    Paul, Barry
    Bhutani, Manisha
    Varga, Cindy
    Ferreri, Christopher
    Atrash, Shebli
    BLOOD, 2024, 144 : 2287 - 2288
12345